Security key
45339J105
Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (INDP)
CUSIP: 45339J105
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 1,836,196
- Total 13F value
- $10,466,000
- Share change
- +1,294,401
- SEC-reported price per share
- $5.70
- Number of holders
- 11
- Value change
- +$6,508,484
- Number of buys
- 9
- Number of sells
- 3
- Shares outstanding
- 113,183,288
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
11
Top holders
10
INDP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Indaptus Therapeutics, Inc. SEC filings
Indaptus Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45339J105
Recent filing periods:
Ownership snapshot
Top reported holders of INDP - Indaptus Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
9/10
Latest evidence
30 Sep 2021
13F
3/4/5
Lead comparable stake: 0.34%
1 rows are not safely comparable across share classes.
Showing 1-6 of 10 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 0.34%.
9 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
0.34%
VANGUARD GROUP INC
0.07%
GEODE CAPITAL MANAGEMENT, LLC
0.02%
INVESTMENT HOUSE LLC
0.02%
CITADEL ADVISORS LLC
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
0.34%
|
$2,990,000
381,892 shares
|
— | 30 Sep 2021 |
| VANGUARD GROUP INC |
13F
Company
|
0.07%
|
$594,000
75,841 shares
|
— | 30 Sep 2021 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.02%
|
$214,000
27,450 shares
|
— | 30 Sep 2021 |
| INVESTMENT HOUSE LLC |
13F
Company
|
0.02%
|
$201,000
25,653 shares
|
— | 30 Sep 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.01%
|
$111,000
14,224 shares
|
— | 30 Sep 2021 |
| MARSHALL WACE, LLP |
13F
Company
|
0.01%
|
$100,000
12,780 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
1,836,196
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
9
Q4 2021 holders
11
Holder diff
2
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend